Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

JOURNEY MED CORP (DERM)

69 + Investors. Track Smart Money conviction in DERM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -7
Streak
1Q ▼
Buyers last Q
53%

Smart Money Signals — DERM

Based on 69 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their DERM positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 91% of 3.0Y peak

91% of all-time peak
69 funds currently hold this stock — 91% of the 3.0-year high of 76 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +82% more funds vs a year ago

fund count last 6Q
+31 new funds entered over the past year (+82% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 53% buying

42 buying37 selling
Last quarter: 42 funds bought or added vs 37 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 25 → 15 → 18 → 12. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

58% of holders stayed for 2+ years

■ 58% conviction (2yr+) ■ 19% medium ■ 23% new
40 out of 69 hedge funds have held DERM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +7%, value -35%

Value
-35%
Shares
+6%
Last quarter: funds added +7% more shares while total portfolio value only changed -35%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

6 → 25 → 15 → 18 → 12 new funds/Q
New funds entering each quarter: 25 → 15 → 18 → 12. DERM is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 68% of holders stayed 2+ years

■ 68% veterans ■ 6% 1-2yr ■ 26% new
Of 69 current holders: 47 (68%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 17% AUM from top-100

17% from top-100 AUM funds
25 of 69 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DERM

In 2026 Q1, 42 hedge funds were net buyers of DERM (12 opened a new position, 30 added to an existing one), while 37 reduced or exited (18 trimmed, 19 sold completely) — a 53% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -7 funds (more exits than new entries). Total institutional holders: 69.

Hedge Fund Ownership: DERM

How many hedge funds hold DERM — quarterly history vs. share price
Quarterly hedge fund ownership of DERM vs. share price

Market Analysis: DERM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DERM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy JOURNEY MED CORP (DERM) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DERM has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 54d ago
DERM
+27.2%
XLV
+2.2%

DERM outperformed XLV by +25.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 9d ago
DERM
-5.8%
XLV
+3.3%

Since the filing became public, DERM outperformed XLV by -9.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: DERM
69 + Investors

Track Smart Money conviction in DERM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 69 76 -9.21%
13F Shares 12M 11M 6.95%
Total Value $55M $85M -35.01%
New Positions 12 18 -6
Increased Positions 30 34 -4
Closed Positions 19 7 +12
Reduced Positions 18 13 +5
Total Calls 0 0 -
Total Puts 1 0 100%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: DERM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

69 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DERM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of DERM — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Opaleye Management Inc. 0.59% 960,000 $4.5M
2 TANG CAPITAL MANAGEMENT LLC 0.38% 1,610,000 $7.6M
3 AMERICAN FINANCIAL GROUP INC 0.31% 180,000 $844K
4 Diametric Capital, LP 0.24% 196,412 $921K
5 Pale Fire Capital SE 0.20% 481,987 $2.3M
6 Ikarian Capital, LLC 0.10% 251,436 $1.2M
7 J. Goldman & Co LP 0.07% 500,188 $2.3M
8 WASATCH ADVISORS LP 0.07% 2,133,370 $10.0M
9 Frec Markets, Inc. 0.04% 50,500 $237K
10 Summit Financial, LLC 0.02% 379,807 $1.8M
11 PRELUDE CAPITAL MANAGEMENT, LLC 0.01% 29,894 $140K
12 Gladstone Institutional Advisory LLC 0.00% 26,571 $125K
13 BOOTHBAY FUND MANAGEMENT, LLC 0.00% 67,442 $316K
14 SALEM INVESTMENT COUNSELORS INC 0.00% 14,300 $67K
15 XTX Topco Ltd 0.00% 29,364 $138K
16 RENAISSANCE TECHNOLOGIES LLC 0.00% 242,500 $1.1M
17 Integrated Wealth Concepts LLC 0.00% 40,369 $189K
18 Trexquant Investment LP 0.00% 28,096 $132K
19 Atria Investments, Inc 0.00% 14,451 $68K
20 MILLENNIUM MANAGEMENT LLC 0.00% 383,067 $1.8M
21 Tower Research Capital LLC (TRC) 0.00% 4,584 $21K
22 STATE OF WISCONSIN INVESTMENT BOARD 0.00% 44,704 $210K
23 LAZARD ASSET MANAGEMENT LLC 0.00% 44,898 $211K
24 MetLife Investment Management, LLC 0.00% 12,431 $58K
25 UBS Group AG 0.00% 390,138 $1.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — JOURNEY MED CORP (DERM)

What does the Smart Money Trend signal show for DERM?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their DERM positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for DERM?

Slight buying edge — 53% buying: Last quarter: 42 funds bought or added vs 37 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for DERM holders?

Smaller funds dominant — 17% AUM from top-100: 25 of 69 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held DERM?

58% of holders stayed for 2+ years: 40 out of 69 hedge funds have held DERM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy JOURNEY MED CORP (DERM) following the 2026 Q1 hedge fund 13F filings?

As of today, DERM has moved -5.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.3% for the XLV sector ETF — an outperformance of -9.1%. Since the quarter end (March 31, 2026), DERM has gained +27.2% vs +2.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →